CLSI MM19
Establishing Molecular Testing in Clinical Laboratory Environments, 1st Edition
This guideline provides comprehensive guidance for planning and implementation of molecular diagnostic testing, including strategic planning, regulatory requirements, implementation, quality management, and special considerations for the subspecialties of molecular genetics, infectious diseases, oncology, and pharmacogenetics.
This document is available in electronic format only.
Member price:
List Price:Details
Chairholder: Leslie Hall, MMSc, M(ASCP) and Jean Amos Wilson, PhD, FACMG, CGMB
Date of Publication: November 30, 2011
Order Code PDF: CLSI MM19AE
ISBN Number: 1-56238-774-X
Order Code Print: print not available
Edition: First
Pages: 252
CLSI MM19 Additional Details
If interested in ordering larger quantities of this document in print, please contact us here.
This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of March 2017. Because of its value to the laboratory community, it is being retained in CLSI’s library.